BEIJING (BLOOMBERG) – Sinopharm Group said its second coronavirus vaccine, this one developed by a subsidiary based in Wuhan, is effective in preventing Covid-19 in 72.5 per cent of people, less than its first shot but above the threshold for approval for general use.…

This data comes from the ChinaPulse.com media intelligence and smart news insights platform.